PolyNovo Limited (ASX:PNV)
Australia · Delayed Price · Currency is AUD 1.140
-0.055 (-4.60%)
Nov 14, 2025, 10:09 AM AEST
PolyNovo Revenue
In the fiscal year ending June 30, 2025, PolyNovo had annual revenue of 128.70M AUD with 24.67% growth. PolyNovo had revenue of 69.16M in the half year ending June 30, 2025, with 90.62% growth.
Revenue
128.70M
Revenue Growth
+24.67%
P/S Ratio
6.41
Revenue / Employee
427.57K
Employees
301
Market Cap
825.56M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 128.70M | 25.47M | 24.67% |
| Jun 30, 2024 | 103.23M | 37.56M | 57.20% |
| Jun 30, 2023 | 65.67M | 23.78M | 56.76% |
| Jun 30, 2022 | 41.89M | 12.55M | 42.78% |
| Jun 30, 2021 | 29.34M | 7.15M | 32.19% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CSL Limited | 23.73B |
| Ramsay Health Care | 17.79B |
| Sonic Healthcare | 9.65B |
| Ansell | 3.06B |
| Cochlear | 2.34B |
| Regis Healthcare | 1.16B |
| Telix Pharmaceuticals | 1.01B |
| Neuren Pharmaceuticals | 218.86M |
PolyNovo News
- 16 days ago - PolyNovo Limited (CALZF) Shareholder/Analyst Call Transcript - Seeking Alpha
- 17 days ago - David Williams exits PolyNovo after investors vote against re-election - The Australian Financial Review
- 18 days ago - ASX 200 LIVE: ASX to rise; PolyNovo jumps after chairman David Williams resigns - The Australian Financial Review
- 4 weeks ago - ASX200 LIVE: ASX resets record high; real estate stocks, gold miners rip - The Australian Financial Review
- 2 months ago - ASX falls, weighed down by health sector; gold stocks surge - The Australian Financial Review
- 2 months ago - ASX 200 LIVE: ASX to fall; Collins Foods reaffirms guidance, gold nears $US3500 - The Australian Financial Review
- 8 months ago - PolyNovo chief executive steps down after dispute with chairman - The Australian Financial Review
- 8 months ago - David Williams says he makes no apologies for ‘aggressive’ style - The Australian Financial Review